Hinge Bio (Series A)

Funding Details
Awarder
Inbox
Date Award
January 15, 2025
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$30,000,000

Company Info
Founders
Barry Selick
Company Description
Hinge Bio specializes in leveraging its proprietary Flex-Hinge antibody platform to develop bispecific and multispecific antibodies.
Market
Therapeutics for autoimmune, inflammatory, infectious diseases, and cancer
Location
Burlingame, CA, USA
Coinvestors
InVivium Capital, Lightswitch Capital, Point72 Ventures, Ridgeback Capital Management

Links